Breakthrough ovarian cancer drug improves patient outcomes
This breakthrough comes at a critical time, as ovarian cancer remains one of the deadliest forms of cancer for women, with an estimated 313,000 new cases diagnosed globally each year. The drug targets specific genetic mutations found in a subset of ovarian cancer patients, marking a shift towards more personalized medicine in oncology. For more … Read more